Contract WinApr 9, 2026, 08:32 AM
Sonoma Pharmaceuticals Enters Manufacturing and Supply Agreement with Kenvue Brands for Microcyn® Products in US
AI Summary
Sonoma Pharmaceuticals, Inc. has announced a new Manufacturing and Supply Agreement with Kenvue Brands LLC, effective October 24, 2025. This agreement focuses on the sale of Sonoma's proprietary Microcyn® technology-based products within the United States. The initial term of the agreement extends through March 2027, with a provision for up to two additional one-year extensions upon mutual written consent. This partnership is strategically significant for Sonoma, as it leverages Kenvue's market presence to expand the distribution and availability of its advanced wound care and dermatological products across the U.S. market, potentially driving future revenue growth and strengthening its competitive position.
Key Highlights
- Sonoma Pharmaceuticals, Inc. entered into a Manufacturing and Supply Agreement with Kenvue Brands LLC.
- The agreement is for the sale of Sonoma's Microcyn® technology-based products.
- The geographic scope of the agreement is the United States.
- The agreement became effective on October 24, 2025.
- The initial term of the agreement runs through March 2027.
- The agreement includes an option for up to two additional one-year terms, subject to mutual written agreement.